ライフサイエンスコーパス: Cryptosporidium

1 ot an important predictor of the presence of Cryptosporidium.

2 The PECs were infected with Cryptosporidium.

3 Most pathogens were Giardia or Cryptosporidium.

4 te reductase (DHFR) as a potential target in Cryptosporidium.

5 l Salmonella (48%), Campylobacter (38%), and Cryptosporidium (8%) species.

6 l Salmonella (62%), Campylobacter (22%), and Cryptosporidium (9%) were also responsible for the major

7 Tyzzer discovered the genus Cryptosporidium a century ago, and for almost 70 years c

8 alysis of any transcription factor family in Cryptosporidium, a basal-branching apicomplexan that is

9 ts/g (about 1 oocyst/g for a pica child) for Cryptosporidium, about 5 MPN/g (about 1 MPN/g for pica)

10 he findings of this study not only validated Cryptosporidium ACS (and related acyl-[acyl-carrier-prot

11 Cryptosporidium ACSs displayed substrate preference towa

12 In this study, we evaluated the anti-Cryptosporidium activity of a novel CDPK1 inhibitor, 129

13 coli (AF, 14.5% [95% CI, 10.2%-22.8%]), and Cryptosporidium (AF, 7.9% [95% CI, 6.2%-9.3%]).

14 Giardia duodenalis, Cryptosporidium, Ancylostoma, Uncinaria, and Toxocara ca

15 n pathogens, such as Plasmodium, Toxoplasma, Cryptosporidium and Babesia species.

16 t of detection (LD), ca. 0.05 raw no's/L for Cryptosporidium and ca. 0.10 raw no's/L for Giardia.

17 alence is estimated to decline by 10.5% with Cryptosporidium and E. coli prevalence increasing by 9.9

18 Through case studies using Cryptosporidium and Escherichia coli, we show that failu

19 We modeled observed Cryptosporidium and Giardia contamination in community p

20 emental Survey (ICR SS) required analysis of Cryptosporidium and Giardia in 10 L surface water sample

21 Data analysis illustrates key features of Cryptosporidium and Giardia in surface water: presence i

22 The data describe Cryptosporidium and Giardia in watersheds nation-wide ov

23 The data and analysis illustrate features of Cryptosporidium and Giardia occurrence in surface water

24 Alcorfix effectively fixed live Cryptosporidium and microsporidia such that morphology a

25 tudying host-parasite interactions involving Cryptosporidium and other intestinal pathogens.

26 s several important human pathogens, such as Cryptosporidium and Plasmodium falciparum, the causative

27 reduced risk of microbial pathogens such as Cryptosporidium and reduced production of regulated drin

28 gG) and immunoglobulin A (IgA) antibodies to Cryptosporidium and rotavirus, and the lactulose to mann

29 ProD was associated with Cryptosporidium and Shigella infections.

30 rks for Toxoplasma gondii, Neospora caninum, Cryptosporidium and Theileria species, and Babesia bovis

31 ty analysis of protozoan pathogens including Cryptosporidium and/or Giardia at the single (oo)cyst le

32 Detection of Cryptosporidium and/or Giardia in a tubewell was positiv

33 a include detectable parasitic (eg, Giardia, Cryptosporidium) and bacterial (eg, enteroaggregative Es

34 in 23500 for Campylobacter, 1 in 5050000 for Cryptosporidium, and 1 in 118000 for rotavirus.

35 r veterinary importance, such as Plasmodium, Cryptosporidium, and Eimeria.

36 6, and 9 parasites per reaction for Giardia, Cryptosporidium, and Entamoeba parasites, respectively.

37 opies per reaction of the synthetic Giardia, Cryptosporidium, and Entamoeba targets, respectively (ro

38 to detect the presence of DNA from Giardia, Cryptosporidium, and Entamoeba.

39 ny of the diarrhea-causing protozoa Giardia, Cryptosporidium, and Entamoeba.

40 t birth had increased Entamoeba histolytica, Cryptosporidium, and ETEC infections and more severe dia

41 We used reference pathogens Campylobacter, Cryptosporidium, and rotavirus as conservative risk prox

42 Rotavirus, norovirus genogroup II, Cryptosporidium, and Shigella species/enteroinvasive Esc

43 ites include those of the genera Plasmodium, Cryptosporidium, and Toxoplasma and those of the relativ

44 ion within 50 m and the sheep population for Cryptosporidium, and with the village illiteracy rate fo

45 The protozoan parasites of the genus Cryptosporidium are increasingly recognized to be respon

46 e countries have confirmed the importance of cryptosporidium as a cause of diarrhoea and childhood ma

47 ldren have identified the protozoan parasite Cryptosporidium as the second most important diarrhoeal

48 The RPA-based Cryptosporidium assay (RPAC assay) was developed and opt

49 The molecular mechanisms underlying Cryptosporidium attachment to, and invasion of, host cel

50 resent data that suggest these cells support Cryptosporidium better than existing cell lines.

51 (hERG) activity of the first-generation anti-Cryptosporidium BKIs triggered further testing for effic

52 ve nearly identical in vitro potency against Cryptosporidium but display divergent PK properties.

53 and her brother and dog were diagnosed with Cryptosporidium canis infections during the same period.

54 lso preferentially used O&P over EIA, but no Cryptosporidium cases were detected by O&P.

55 Cryptosporidium causes significant diarrhea worldwide, e

56 The apicomplexan parasite Cryptosporidium causes significant diarrheal disease wor

57 We have shown that several BKIs of Cryptosporidium CDPK1 potently reduce enzymatic activity

58 The Giardia/Cryptosporidium Chek test (TechLab, Inc.), a screening t

59 Cryptosporidium chipmunk genotype I is an emerging zoono

60 Thus, Cryptosporidium chipmunk genotype I isolates from humans

61 C. andersoni, C. ubiquitum, C. tyzzeri, and Cryptosporidium chipmunk genotype I were processed with

62 s sporozoites directly into the intestine, a Cryptosporidium clustered regularly interspaced short pa

63 etting is expected to marginally reduce pond Cryptosporidium contamination (16%) while increasing loc

64 ementing 3-log10 inactivation conditions for Cryptosporidium (CT value = 15300 mg.min/L) to remediate

65 importance, including Eimeria, Sarcocystis, Cryptosporidium, Cyclospora, and Plasmodium species.

66 New literature on key pathogens Cryptosporidium, Cyclospora, Isospora, Giardia, and Enta

67 unoassays are more sensitive for Giardia and Cryptosporidium detection, but our experience was that p

68 ance-based device is able to get insights on Cryptosporidium development on a cell culture and to qua

69 ectively for the isolation and enrichment of Cryptosporidium DNA from fecal specimens for whole-genom

70 ITGA2 might be involved in interacting with Cryptosporidium during infection, probably acting as par

71 d Giardia EIA, and 5.7% (n = 9,754) included Cryptosporidium EIA.

72 2), serum MBL deficiency, and infection with Cryptosporidium, Entamoeba histolytica, and Giardia inte

73 rhoea were due to four pathogens: rotavirus, Cryptosporidium, enterotoxigenic Escherichia coli produc

74 ova/parasite (O&P) examinations, and Giardia/Cryptosporidium enzyme immunoassay screens (GC-EIA) perf

75 ortant factors that determine the outcome of Cryptosporidium exposure.

76 sensor to detect different concentrations of Cryptosporidium, for which it is shown that the sample d

77 l method provides a novel means of silencing Cryptosporidium genes to study their role in host-parasi

78 Use of cryptosporidium genomes has helped to identify promising

79 ing sequence data covering 94.5% to 99.7% of Cryptosporidium genomes, with mostly minor contamination

80 ocedures for the isolation and enrichment of Cryptosporidium genomic DNA from fecal specimens and ver

81 proportion of positive colonies derived from Cryptosporidium genomic DNA, </=25%).

82 as shown to be waterborne; and (iv) study of Cryptosporidium genomics.

83 These results demonstrate that different Cryptosporidium genotypes and subtype families are linke

84 ors or for water monitoring specifically for Cryptosporidium, Giardia and microsporidia.

85 lla/enteroinvasive E. coli (EIEC), protozoa (Cryptosporidium, Giardia lamblia, and Entamoeba histolyt

86 ering the eukaryotic pathogens of the genera Cryptosporidium, Giardia, Leishmania, Neospora, Plasmodi

87 ruses and rotaviruses) and protozoa (such as Cryptosporidium, Giardia, or Entamoeba histolytica) disr

88 ncrease in immunoglobulin G directed against Cryptosporidium gp15 and/or Cp23 antigens between consec

89 Cryptosporidium hominis (73.3%) was the predominant Cryp

90 rofolate reductase-thymidylate synthase from Cryptosporidium hominis and a homology model of DHFR fro

91 ntiation of the most common human pathogens, Cryptosporidium hominis and Cryptosporidium parvum, but

92 Cryptosporidium hominis and Cryptosporidium parvum, whic

93 eba histolytica, Cryptosporidium parvum, and Cryptosporidium hominis Similarly, these species cause t

94 -specific lectin isolated from C. parvum and Cryptosporidium hominis sporozoites by Gal-affinity chro

95 One previously rare Cryptosporidium hominis subtype was identified in 40 cas

96 The essential enzyme TS-DHFR from Cryptosporidium hominis undergoes an unusually rapid rat

97 Cyclospora papionis, Cryptosporidium hominis, and Enterocytozoon bieneusi wer

98 as inhibitors of Cryptosporidium parvum and Cryptosporidium hominis.

99 40 cases (70%) from all four states, and the Cryptosporidium horse genotype was identified in a pet s

100 Although the mechanisms underlying Cryptosporidium-host cell interactions are not well unde

101 because the molecular mechanisms underlying Cryptosporidium-host cell interactions are poorly unders

102 y implicate a significant role for CpClec in Cryptosporidium-host cell interactions.

103 6; 1.6-4.1) in infants aged 0-11 months, and Cryptosporidium (HR 2.3; 1.3-4.3) in toddlers aged 12-23

104 Using the results of the Giardia II test and Cryptosporidium II test as gold standards, it was 98.4%

105 g more than 10,000 population to analyze for Cryptosporidium in at least 24 consecutive monthly sampl

106 native to hyperchlorination for inactivating Cryptosporidium in chlorinated recreational water venues

107 xide (ClO2) to achieve 2-log inactivation of Cryptosporidium in drinking water has been documented.

108 le of predicting the presence of Giardia and Cryptosporidium in fresh surface waters in the Chicago a

109 he prediction of the presence of Giardia and Cryptosporidium in our location and were closely aligned

110 Recent rainfall increased the risk of Cryptosporidium in STWs (an extreme event) and ponds (an

111 %), with the largest increases predicted for Cryptosporidium in STWs.

112 are used to achieve a 3-log inactivation of Cryptosporidium in such venues.

113 andidate for treatment of diarrhea caused by Cryptosporidium in young children in the resource-limite

114 Currently, CYA's impact on Cryptosporidium inactivation is not fully determined.

115 the investigation of the process involved in Cryptosporidium-induced cell transformation.

116 Toxoplasma and Cryptosporidium infect millions of people each year with

117 th no apparent toxicity when administered to Cryptosporidium-infected interleukin 12 knockout mice at

118 el TRAIL-mediated pathway for elimination of Cryptosporidium infection and a role for OPG in modulati

119 Diagnostic tests for cryptosporidium infection are suboptimum, necessitating

120 KDU731, a PI (4) kinase inhibitor, blocks Cryptosporidium infection in vitro and in vivo in immuno

121 ut the role of IL-18 in innate resistance to Cryptosporidium infection is unknown.

122 odel system capable of supporting continuous Cryptosporidium infection will be a useful tool for the

123 ct in vivo efficacy with a neonatal model of Cryptosporidium infection, these concentrations in the l

124 genetic component of the immune response to Cryptosporidium infection, which includes HLA class I an

125 ultivation of PECs that can be used to study Cryptosporidium infection.

126 fic gut microbial and biochemical effects of Cryptosporidium infection.

127 rther supported with an adult mouse model of Cryptosporidium infection.

128 or effective drug treatment exist to combat Cryptosporidium infection.

129 duals at increased risk for non-Giardia, non-Cryptosporidium infection.

130 aluate the mechanism of protection of MBL in Cryptosporidium infection.

131 six children (42.5%) received a diagnosis of Cryptosporidium infection.

132 , Peru, and 230 were microscopy positive for Cryptosporidium infection.

133 cing (IP) gut microbiota on the outcome of a Cryptosporidium infection.

134 Cryptosporidium infections have been associated with gro

135 We found that average outbreak size of Cryptosporidium infections in sifakas was larger when th

136 uffering from recurrent bacterial, viral and Cryptosporidium infections, and identify a biallelic mut

137 MBL2 haplotype were strongly associated with Cryptosporidium infections, particularly recurrent infec

138 Cryptosporidium inosine 5'-monophosphate dehydrogenase (

139 Cryptosporidium is a leading cause of diarrhea in small

140 Cryptosporidium is a leading cause of moderate to severe

141 The protozoan Cryptosporidium is a major public and animal health conc

142 Cryptosporidium is also an opportunistic pathogen in the

143 Cryptosporidium is emerging as 1 of the 4 leading diarrh

144 Understanding the environmental pathways of Cryptosporidium is essential for effective management of

145 gest that, unlike other protozoan parasites, Cryptosporidium is incapable of de novo pyrimidine biosy

146 Cryptosporidium is recognized as one of the main causes

147 ld-killer and famously recalcitrant parasite Cryptosporidium is the latest organism to yield to the m

148 Cryptosporidium is the main origin of worldwide waterbor

149 f mammals, and the CDPK1 of the apicomplexan Cryptosporidium lack side chains that typically block a

150 Our results suggest that the Cryptosporidium lipid kinase PI(4)K (phosphatidylinosito

151 e literature, the hypothesis is offered that Cryptosporidium may be found in surface water anywhere w

152 ted Luminex microspheres that hybridize to a Cryptosporidium microsatellite-2 region (ML-2) where C.

153 e, discrimination of Cryptosporidium parvum, Cryptosporidium muris and Giardia lamblia, with over 92%

154 Through the ANOFEL Cryptosporidium National Network and the French Transpla

155 c Escherichia coli, Shigella, Campylobacter, Cryptosporidium, norovirus GII, and adenovirus.

156 affect infection risks due to Campylobacter, Cryptosporidium, norovirus, and Vibrio.

157 hole, the data describe a spectrum of median Cryptosporidium occurrence in surface waters of the U.S.

158 FCM, was around 30% for Giardia and 13% for Cryptosporidium (oo)cysts.

159 fragment length polymorphism analysis of the Cryptosporidium oocyst wall protein gene for 134 of 136

160 levels of helminth eggs, Giardia cysts, and Cryptosporidium oocysts, but the UASB reactor system dis

161 ignificantly delays chlorine inactivation of Cryptosporidium oocysts, emphasizing the need for additi

162 collected before and after a challenge with Cryptosporidium oocysts.

163 atory nationally (1997 to 2006) and during a Cryptosporidium outbreak (Utah, 2007) to correlate physi

164 fectious disease model to the 1993 Milwaukee Cryptosporidium outbreak, we demonstrate that environmen

165 Cryptosporidium parasites are pathogens of human intesti

166 emerged as a therapeutic target for treating Cryptosporidium parasites because it catalyzes a critica

167 Oral therapy with 1294 eliminated Cryptosporidium parasites from 6 of 7 infected severe co

168 Cryptosporidium parasites infect intestinal cells, causi

169 In a recent study, the dependence of Cryptosporidium parasites on a single salvage pathway th

170 by lack of methods to genetically manipulate Cryptosporidium parasites.

171 IMPDH from the pathogenic protozoan parasite Cryptosporidium parvum ( CpIMPDH), which was obtained fr

172 uantitative detection of Giardia lamblia and Cryptosporidium parvum (oo)cysts in a field campaign.

173 chemical features and inhibitory kinetics of Cryptosporidium parvum ACSs using recombinant proteins.

174 identify pyrazolopyridines as inhibitors of Cryptosporidium parvum and Cryptosporidium hominis.

175 mechanism induced by the protozoan parasite Cryptosporidium parvum and Gram(-) bacteria-derived lipo

176 Cryptosporidium parvum and related species are zoonotic

177 effects of silver salt and nanoparticles on Cryptosporidium parvum and the removal of C. parvum by p

178 picomplexan protozoans Toxoplasma gondii and Cryptosporidium parvum are a major health concern.

179 sly, we identified and characterized a novel Cryptosporidium parvum C-type lectin domain-containing m

180 Bumped kinase inhibitors (BKIs) of Cryptosporidium parvum calcium-dependent protein kinase

181 mologous loop from the apicomplexan parasite Cryptosporidium parvum does not affect TLR11-dependent I

182 rays (IMA's) during 76h and then infected by Cryptosporidium parvum during 60h.

183 Severe experimental infections with Cryptosporidium parvum have been reported in immunocompr

184 In this study, 111 Cryptosporidium parvum IId isolates from several species

185 ition, the inhibitory potential of two known Cryptosporidium parvum IMPDH inhibitors was examined for

186 The half maximal effective concentration for Cryptosporidium parvum in HCT-8 cells was determined to

187 ntrolling enteric infection by the protozoan Cryptosporidium parvum in neonatal mice.

188 We report here that the protozoan parasite Cryptosporidium parvum induced B7-H1 expression in cultu

189 on or infection with the parasitic protozoan Cryptosporidium parvum induced expression of CIS protein

190 liary epithelial cells (cholangiocytes) with Cryptosporidium parvum induces Toll-like receptor (TLR)

191 We have demonstrated previously that Cryptosporidium parvum infection down-regulates microRNA

192 effect of short-term protein malnutrition on Cryptosporidium parvum infection in a murine model by ex

193 Recovery from Cryptosporidium parvum infection in adult hosts involves

194 The impact of Cryptosporidium parvum infection on host cell gene expre

195 ells, and B cells demonstrated resistance to Cryptosporidium parvum infection that was IFN-gamma depe

196 We used a piglet model of Cryptosporidium parvum infection to determine how elimin

197 reviously) to support long-term infection by Cryptosporidium parvum Infection was assessed by immunof

198 Cryptosporidium parvum is a major cause of diarrheal ill

199 Cryptosporidium parvum is a potential biowarfare agent,

200 Cryptosporidium parvum is a waterborne pathogen, yet no

201 Cryptosporidium parvum is an enteric protozoan parasite

202 Cryptosporidium parvum is an important human pathogen an

203 Cryptosporidium parvum is an important opportunistic par

204 Cryptosporidium parvum is an obligate intracellular prot

205 Cryptosporidium parvum is an opportunistic pathogen in A

206 surface charge heterogeneity on transport of Cryptosporidium parvum oocyst and carboxylate microspher

207 Transport of Cryptosporidium parvum oocysts and microspheres in two d

208 Effective removal of Cryptosporidium parvum oocysts by granular filtration re

209 r the detection of mRNA targets derived from Cryptosporidium parvum oocysts by the use of oligonucleo

210 Protein-deficient mice were infected with Cryptosporidium parvum oocysts for 6-13 days and compare

211 vitro and in vivo) and unexcysted (in vivo) Cryptosporidium parvum oocysts in human colonic adenocar

212 riments was performed with freshly harvested Cryptosporidium parvum oocysts to evaluate the effects o

213 ore, the induced expression of HSP70 mRNA in Cryptosporidium parvum oocysts via a simple heat shock p

214 ing-wall vessel (RWV) and were infected with Cryptosporidium parvum oocysts.

215 The apicomplexan pathogen Cryptosporidium parvum poses major logistical problems i

216 human intestinal epithelial cells (HCT-8) by Cryptosporidium parvum resulted in a rapid induction of

217 The hsp70 mRNA from Cryptosporidium parvum was used as a model analyte.

218 Recombinant progeny lines of Cryptosporidium parvum were generated by coinfecting imm

219 y Giardia duodenalis, Entamoeba histolytica, Cryptosporidium parvum, and Cryptosporidium hominis Simi

220 CDPK1 was cloned from the genome of Cryptosporidium parvum, and potent and specific inhibito

221 human pathogens, Cryptosporidium hominis and Cryptosporidium parvum, but also simultaneous amplificat

222 Altogether, 24 fecal specimens of Cryptosporidium parvum, C. hominis, C. andersoni, C. ubi

223 The three protozoan species Cryptosporidium parvum, C. meleagridis and C. hominis (p

224 Surprisingly, during infection by Cryptosporidium parvum, CCL20 production by the intestin

225 Furthermore, discrimination of Cryptosporidium parvum, Cryptosporidium muris and Giardi

226 with the intracellular apicomplexan parasite Cryptosporidium parvum, infected and uninfected cells we

227 idiosis, caused by the apicomplexan parasite Cryptosporidium parvum, is a diarrheal disease that has

228 Cryptosporidium parvum, Leishmania spp., Trypanosoma cru

229 cholangiocytes with the protozoan parasite, Cryptosporidium parvum, or treatment with gram-negative

230 bligate intracellular apicomplexan parasite, Cryptosporidium parvum, results in the formation of a un

231 odium falciparum, the parasitic Apicomplexan Cryptosporidium parvum, the yeast Saccharomyces cerevisi

232 Cryptosporidium hominis and Cryptosporidium parvum, which infect humans equally, are

233 c-specific lectin activity in sporozoites of Cryptosporidium parvum.

234 Despite its impact on human health, Cryptosporidium pathogenesis remains poorly known, mainl

235 are not substrates for CpTK, indicating that Cryptosporidium possesses another deoxynucleoside kinase

236 eer this parasite will be transformative for Cryptosporidium research.

237 55 and 0-240 oo(cysts)/liter for Giardia and Cryptosporidium, respectively) in 85 to 300 min, with FC

238 RNA (ssRNA), we induced specific slicing in Cryptosporidium RNA targets.

239 RBF on consumer health burdens for Giardia, Cryptosporidium, rotavirus, norovirus, and adenovirus in

240 ) threshold cycle (CT) values yielded mostly Cryptosporidium sequences in Sanger sequencing.

241 Giardia and Cryptosporidium shedding increased near large human popu

242 Norovirus GII, Cryptosporidium, Shigella, ST-ETEC, and adenovirus 40/41

243 ith the human enzyme Argonaute 2 (hAgo2) and Cryptosporidium single-stranded RNA (ssRNA), we induced

244 ecies (127 155; 90% CrI, 66 502-219 886) and Cryptosporidium species (113 344; 90% CrI, 22 570-299 24

245 Cryptosporidium species are a common cause of diarrhea,

246 Cryptosporidium species are waterborne apicomplexan para

247 nd during diarrheal episodes were tested for Cryptosporidium species by polymerase chain reaction (PC

248 pisodes, and were tested for the presence of Cryptosporidium species by polymerase chain reaction.

249 nucleic acid test to detect the presence of Cryptosporidium species in DNA extracted from stool samp

250 rs, testing positive for either rotavirus or Cryptosporidium species in stool (coinfections were excl

251 the prevention of Entamoeba histolytica and Cryptosporidium species infection in children living in

252 ) is widely used to study gene function, but Cryptosporidium species lack the enzymes necessary to pr

253 wing this strategy, 20 WGA products from six Cryptosporidium species or genotypes with low (mostly <1

254 Diarrhea associated with Cryptosporidium species tended to be longer in duration

255 Entamoeba histolytica, Giardia enterica, and Cryptosporidium species were detected by commercially av

256 poridium hominis (73.3%) was the predominant Cryptosporidium species, and there was no species-specif

257 For Cryptosporidium species, it had a sensitivity and specif

258 ach is very effective for differentiation of Cryptosporidium species, it is labor-intensive and time-

259 groups of pathogens: Campylobacter species, Cryptosporidium species, Shiga toxin-producing Escherich

260 ing direct sequence analysis to identify any Cryptosporidium species.

261 Subtyping was conducted in late 2007 on 57 Cryptosporidium specimens from sporadic cases in Colorad

262 MBL has been shown to bind to Cryptosporidium sporozoites, and earlier work has sugges

263 Blastocystis hominis (1.03, 0.87-1.23), and Cryptosporidium spp (0.68, 0.17-2.68).

264 %, 0.4-6.3), astrovirus (2.7%, 2.2-3.1), and Cryptosporidium spp (2.0%, 1.3-2.6) exhibited the highes

265 Cryptosporidium spp are well recognised as causes of dia

266 0.99), G intestinalis (0.63, 0.50-0.80), and Cryptosporidium spp infections (0.83, 0.70-0.98).

267 a spp, rotavirus, adenovirus 40/41, ST-ETEC, Cryptosporidium spp, and Campylobacter spp.

268 ects but does not differentiate Giardia spp, Cryptosporidium spp, and Entamoeba histolytica, the Tri-

269 Campylobacter jejuni and Campylobacter coli, Cryptosporidium spp, enteropathogenic Escherichia coli,

270 Cryptosporidium spp. are apicomplexan parasites of globa

271 Cryptosporidium spp. cause acute gastrointestinal diseas

272 The genetic diversity of Cryptosporidium spp. from infected children was characte

273 on that the risk of zoonotic transmission of Cryptosporidium spp. from pet cats and dogs is low.

274 o streamline detection and identification of Cryptosporidium spp. in human clinical samples.

275 Whole-genome sequencing of Cryptosporidium spp. is hampered by difficulties in obta

276 l GloWPa-Crypto L1 calculates a total global Cryptosporidium spp. load from livestock manure of 3.2 x

277 In this paper we aim to quantify livestock Cryptosporidium spp. loads to land on a global scale usi

278 e of humans and neonatal livestock caused by Cryptosporidium spp. that infect epithelial cells.

279 sinia enterocolitica, Entamoeba histolytica, Cryptosporidium spp., and E. coli O157:H7; 95% for Giard

280 dium difficile), parasites (Giardia lamblia, Cryptosporidium spp., and Entamoeba histolytica), and vi

281 Molecular characterization of Cryptosporidium spp., critical to epidemiological analys

282 O157), Shigella spp./enteroinvasive E. coli, Cryptosporidium spp., Cyclospora cayetanensis, Entamoeba

283 ped countries, including Giardia lamblia and Cryptosporidium spp., using technologies that, if expand

284 lia (syn. G. intestinalis/G. duodenalis) and Cryptosporidium spp., using technologies that, if expand

285 ceptible-exposed-infected-recovered model of Cryptosporidium spread in wild Verreaux's sifakas.

286 icomplexan intestinal parasites of the genus Cryptosporidium take a major toll on human and animal he

287 logical studies found the protozoan parasite Cryptosporidium to be a leading cause of paediatric diar

288 s indole alone, can influence the ability of Cryptosporidium to establish an infection.

289 n parasites, such as Plasmodium, Toxoplasma, Cryptosporidium, trypanosomes, and Leishmania, are a maj

290 ive pathogens (rotavirus, Shigella, ST-ETEC, Cryptosporidium, typical enteropathogenic E coli) can su

291 s and genotypes can infect humans, including Cryptosporidium viatorum, which, to date, has only been

292 ctions were mainly asymptomatic (693 [66%]), Cryptosporidium was identified in 9.4% of diarrheal epis

293 Cryptosporidium was not found in any sample.

294 Lab, Inc.), a screening test for Giardia and Cryptosporidium, was evaluated with 136 fecal samples.

295 Giardia and Cryptosporidium were detected in canal waters.

296 In the required sample volumes of 10 L no Cryptosporidium were found in 86% of samples and no Giar

297 No Cryptosporidium were found in 93% of samples and no Cryp

298 poridium were found in 93% of samples and no Cryptosporidium were found in any samples analyzed from

299 tions representing every region of the U.S., Cryptosporidium were found in sufficient numbers of samp

300 Children with multiple infections with Cryptosporidium were more likely to be MBL deficient (od